IBM Slips as Cash Allocation Concerns Offset Software Gains

What happened

IBM shares edged down 0.87% to $249.91 after its latest earnings showed improved software performance but raised questions about how the company is deploying its cash. The software segment's 8.7% constant-currency growth was fueled by a catch-up of delayed deals from the prior quarter and the contribution of recently acquired Confluent and HashiCorp, rather than broad-based organic demand. Meanwhile, Consulting grew only 2% constant currency, and Automation declined 3.3%, signaling that enterprise AI spending has not yet translated into across-the-board momentum. Management's aggressive acquisition strategy—$12.6 billion spent year-to-date, including $11.6 billion for Confluent—has pushed net debt to $53.5 billion and reduced cash balances, prompting investor scrutiny of capital allocation. With the stock trading at 21 times earnings and 16.9 times EV/EBITDA, the current valuation already embeds much of the recovery narrative, leaving limited margin of safety for new buyers.

Implication

The next earnings report will be critical: if software growth holds above 7% without another round of delayed-deal explanations and Automation turns positive, the thesis improves. However, even in that scenario, the stock's upside may be capped because the market has already priced in a recovery, as evidenced by the stock's rebound from its summer lows. A more attractive entry point sits near $225, where the risk-reward becomes more favorable, while trimming above $280 would be prudent if the stock runs ahead of fundamentals. Investors should also watch Consulting growth; if it remains stuck in low single digits, the bull case for broad AI monetization weakens. Finally, the heavy acquisition spending and rising debt load mean dividend sustainability and future buybacks could be constrained, adding another reason to demand a higher margin of safety.

Thesis delta

No material shift to the existing WAIT thesis. The news reinforces concerns about cash allocation after the Confluent acquisition, but does not alter the core view that IBM offers durable cash flow with limited near-term upside. The focus on software earnings improvement is tempered by the fact that growth was partly inorganic and deal-timing driven.